Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Feb;16(1):127-35.
doi: 10.1007/s11307-013-0670-7.

Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma

Affiliations
Clinical Trial

Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma

Takaaki Beppu et al. Mol Imaging Biol. 2014 Feb.

Abstract

Purpose: The aim of this study was to clarify the reliability of positron emission tomography (PET) using a new hypoxic cell tracer, 1-(2-[(18)F]fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole ((18)F-FRP170).

Procedures: Twelve patients with glioblastoma underwent (18)F-FRP170 PET before tumor resection. Mean standardized uptake value (SUV) and normalized SUV were calculated at regions within a tumor showing high (high-uptake area) and relatively low (low-uptake area) accumulations of (18)F-FRP170. In these areas, intratumoral oxygen pressure (tpO2) was measured using microelectrodes during tumor resection.

Results: Mean tpO2 was significantly lower in the high-uptake area than in the low-uptake area. A significant negative correlation was evident between normalized SUV and tpO2 in the high-uptake area.

Conclusion: The present findings suggest that high accumulation on (18)F-FRP170 PET represents viable hypoxic tissues in glioblastoma.

PubMed Disclaimer

References

    1. J Nucl Med. 2005 Feb;46(2):253-60 - PubMed
    1. J Nucl Med. 2012 Oct;53(10):1608-15 - PubMed
    1. Ann Nucl Med. 2007 Feb;21(2):101-7 - PubMed
    1. J Nucl Med. 2008 Jun;49 Suppl 2:129S-48S - PubMed
    1. J Pharm Pharm Sci. 2007;10(2):203-11 - PubMed

Publication types

MeSH terms

LinkOut - more resources